These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8291065)

  • 1. Dose-response relationships in mice following subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: CYP1A1, CYP1A2, estrogen receptor, and protein tyrosine phosphorylation.
    DeVito MJ; Ma X; Babish JG; Menache M; Birnbaum LS
    Toxicol Appl Pharmacol; 1994 Jan; 124(1):82-90. PubMed ID: 8291065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of subchronic 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on immune system and target gene responses in mice: calculation of benchmark doses for CYP1A1 and CYP1A2 related enzyme activities.
    Vogel C; Donat S; Döhr O; Kremer J; Esser C; Roller M; Abel J
    Arch Toxicol; 1997; 71(6):372-82. PubMed ID: 9195019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationships of tissue distribution and induction of CYP1A1 and CYP1A2 enzymatic activities following acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in mice.
    Diliberto JJ; Akubue PI; Luebke RW; Birnbaum LS
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):197-208. PubMed ID: 7871533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative sensitivities of 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced Cyp1a-1 and Cyp1a-2 gene expression and immunotoxicity in female B6C3F1 mice.
    Narasimhan TR; Craig A; Arellano L; Harper N; Howie L; Menache M; Birnbaum L; Safe S
    Fundam Appl Toxicol; 1994 Nov; 23(4):598-607. PubMed ID: 7867912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
    Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization of TCDD differs between the liver, lungs, and kidneys after acute and subchronic exposure: species/dose comparisons and possible mechanism.
    Santostefano MJ; Johnson KL; Whisnant NA; Richardson VM; DeVito MJ; Diliberto JJ; Birnbaum LS
    Fundam Appl Toxicol; 1996 Dec; 34(2):265-75. PubMed ID: 8954756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between CYP1A enzyme activities and protein levels in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    DeVito MJ; Beebe LE; Menache M; Birnbaum LS
    J Toxicol Environ Health; 1996 Mar; 47(4):379-94. PubMed ID: 8600290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of pharmacokinetics in determining the relative potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,3,7,8-tetrachlorodibenzofuran.
    DeVito MJ; Birnbaum LS
    Fundam Appl Toxicol; 1995 Jan; 24(1):145-8. PubMed ID: 7713338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cytochrome P450 isoenzymes after toxicokinetic interactions between 2,3,7,8-tetrachlorodibenzo-p-dioxin and 2,2',4,4',5,5'-hexachlorobiphenyl in the liver of the mouse.
    De Jongh J; DeVito M; Nieboer R; Birnbaum L; Van den Berg M
    Fundam Appl Toxicol; 1995 May; 25(2):264-70. PubMed ID: 7665010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biphasic response for hepatic microsomal enzyme induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in C57BL/6J and DBA/2J mice.
    Shen ES; Guengerich FP; Olson JR
    Biochem Pharmacol; 1989 Nov; 38(22):4075-84. PubMed ID: 2512931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls.
    DeVito MJ; Ménache MG; Diliberto JJ; Ross DG; Birnbaum LS
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):157-72. PubMed ID: 10986007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and biological activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Dose-dependent tissue distribution and induction of hepatic ethoxyresorufin O-deethylase in rats following a single injection.
    Abraham K; Krowke R; Neubert D
    Arch Toxicol; 1988; 62(5):359-68. PubMed ID: 3242446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subchronic Exposure of [3H]- 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in female B6C3F1 mice: relationship of steady-state levels to disposition and metabolism.
    Diliberto JJ; DeVito MJ; Ross DG; Birnbaum LS
    Toxicol Sci; 2001 Jun; 61(2):241-55. PubMed ID: 11353133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of ethoxyresorufin-O-deethylase and inhibition of glucocorticoid receptor binding in skin and liver of haired and hairless HRS/J mice by topically applied 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Stohs SJ; Abbott BD; Lin FH; Birnbaum LS
    Toxicology; 1990 Dec; 65(1-2):123-36. PubMed ID: 2274963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
    Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution after a single subcutaneous administration of 2,3,7,8-tetrabromodibenzo-p-dioxin in comparison with toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Wistar rats.
    Nagao T; Yamashita K; Golor G; Bittmann H; Körner W; Hagenmaier H; Neubert D
    Life Sci; 1996; 58(4):325-36. PubMed ID: 8538369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducibility of cytochromes P-450 by dioxin in liver and extrahepatic tissues of the marmoset monkey (Callithrix jacchus).
    Schulz TG; Neubert D; Davies DS; Edwards RJ
    Biochim Biophys Acta; 1996 Nov; 1298(1):131-40. PubMed ID: 8948497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.